The COVID-19 pandemic progresses across the globe at pace, bringing
devastating consequences and lockdown of countries and continents.
Looking for some brief distraction from the daily news reports, I was
drawn to recent apparently random observations that SARS-COV-2 can
infect other animal species, especially cats. On 6 April 2020 it was
reported that a number of big cats at the Bronx zoo had developed
respiratory symptoms, and that a tiger named Nadia had been tested
positive for a COVID-19 (1, 2). It is assumed that the infection was
transmitted by a zookeeper who had fallen ill with COVID-19 and been in
contact with the tiger (2). Who was brave enough to take a throat swab
from a tiger was not revealed.
Recent evidence suggests that cats (but much less so dogs) can be
susceptible to infection with COVID-19, and that the SARS-Cov-2 virus
replicates efficiently in cats and ferrets (3). Unlike the big cats at
Bronx zoo the initial infection was artificially induced by large doses
of SARS-Cov-2, and did not result from exposure to a single infected
human. This study demonstrated that the infected cats were asymptomatic
but were able to infect other nearby cats through droplets spread thus
maintaining the infection chain. The observation has led the Center for
diseases control (CDC) to advise people with symptoms of COVID-19 to
minimise contact with their pets, including petting, snuggling, and
being licked (2). It should be noted that as yet there is no evidence of
pet to human transmission, nor whether cats go on to develop immunity,
but it is hard to ignore the possibility that our pets might act as
reservoirs for SARS-Cov-2. Notwithstanding the possibility that in the
months to come there may be herds of cats immune to COVID-19, it is hard
to escape the likelihood that until either human herd immunity or mass
vaccination against COVID-19 becomes a reality, the SARS-Cov-2 virus is
likely to live on in our communities for some time to come. This is
likely to have implications with respect to the need for some form of
ongoing non-pharmaceutical interventions for the foreseeable future.
The recent observations of COVID-19 infection in cats brought to mind
recent social media posts remembering Erwin Schrodinger’s “cat paradox
paper” (4) - colloquially referred to as Schrodinger’s cat. Given the
lack of mass community testing for SARS-Cov-2 in most countries to date,
the posts suggested that COVID-19 could be considered to be the
‘Schrodinger’s virus’. Unfortunately, it is not possible to cite an
original author as the nature of social media posts usually obscure the
origin, but whoever came up with the concept in to be commended, and if
they can be identified should take significant credit.
In 1935, Schrodinger attempted to describe a paradox in quantum
mechanics which suggests that physical objects can simultaneously exist
in any possible state at any given point in time. The paradox was
postulated by Einstein, and Schrodinger sought to explain the concept to
those with the more average mind. Briefly, he described a cat placed in
a sealed box in which the observer could not see the cat. In the box was
a vial of deadly poison gas, which would be released upon the random
degeneration of a radioactive substance. He explained that at any given
time, the cat will either be alive or dead, but the observer would not
know which state existed for the cat. Therefore, the cat must be assumed
to be both alive and dead at the same time. Whilst Schrodinger’s concept
may seem macabre, it has great relevance to COVID-19 in a situation
where scientists remain in the dark as to the actual extent of community
wide infection rates.
Likening Schrödinger’s cat to ‘Schrodinger’s virus’ is therefore highly
relevant. There is good evidence that people infected with COVID-19, who
by definition must be considered to be infectious, are often
asymptomatic (5) or pre-symptomatic (6). Without regular mass testing of
whole populations it is thus impossible to know in what state
(previously infected and thus probably immune, currently infected, or
not infected) anyone we meet exists. This applies to both healthcare
setting interactions and also any person-to-person interaction in the
community – hence ‘Schrodinger’s virus’. Therefore, in light of a lack
of widespread testing, every human to human interaction has to be
assumed to be both an opportunity to infect the other person or be
infected by them.
This paradox emphasises the need for global leaders of health, national
and international policy, to urgently address what measures are
necessary to prevent the further spread of COVID-19. National and
international lockdown policies cannot stay in place forever, and many
are now discussing exit strategies. A recent paper, yet to be peer
reviewed, but already shared via the SSRN community (7), explores the
impact of nationwide policies for wearing a face mask in public. The
authors point out that the data on COVID-19 to date show that in
countries (all SE Asian) where the universal wearing of facemasks is the
norm, there is a significant reduction in average daily growth rates of
confirmed COVID-19 infection (10% versus 18%). They also model
substantial societal and financial benefits through reduced COVID-19
transmission, healthcare burden, suffering and deaths. It is important
to note that their modelling is based on the use of home-made cloth face
masks, preserving medical masks for frontline health and social care
staff. The CDC in the United States have also released a recommendation
on the use of cloth face masks in public settings (6).
There has been debate for years on the effectiveness of facemasks to
prevent viral transmission in both community and healthcare settings
(8). However, notwithstanding the data on COVID-19 infection rates
highlighted recently (6, 7) there are now fairly compelling data to
support widespread use of facemasks. If used consistently, as is likely
at a time of pandemic, masks have been shown to significantly reduce
transmission from people infected with respiratory pathogens to others
(9) with a reduction of 3.4 fold in viral aerosol shedding of influenza
virus demonstrated through the use of facemasks in another study (10).
For healthcare workers much emphasis has been placed on the difference
between aerosol and droplet spread and the lack of evidence for face
masks with the latter. However, investigators studying the potential
benefit of N95 masks versus conventional medical masks concluded that
this distinction between aerosol and droplets was an oversimplification
(11). They showed that N95 masks, which are masks that are tight fitting
and filtered, provided significantly greater protection than standard
medical masks against contracting respiratory infection in healthcare
workers. Importantly, the relative risk of laboratory confirmed viral
infections overall was reduced to just 0.46 (95% CI 0.23-0.91) when
compared with medical masks, and droplet transmission had an even
greater reduction in relative risk to just 0.26 (95% CI 0.16-0.42)
using N95 masks.
The world will inevitably move towards some form of relaxation of
lockdown in the not too distant future, and this is important for
societal, mental health, and economic reasons. However, it is important
that COVID-19 does not re-emerge in epidemic proportions again as a
result, with similar devastating consequences to those that we are
seeing at present. There appears to be a strong body of evidence, and
also guidance from respected international authorities to support the
use of simple, society wide home-made face masks, and the use of better
protection for healthcare workers exposed to the risk of COVID-19.
Hopefully, combined with ongoing social distancing measures, and
availability of widespread testing facilities to support isolated
quarantine, such an approach might mitigate against the resurgence of
COVID-19 as lockdown measures are relaxed.
There is also a strong case for a thorough evidence based global review
of which masks should be used when, and in what settings. Perhaps, were
Schrödinger’s cat alive, and obviously dead at the same time, in the age
of COVID-19 it would have chosen to wear a mask and also preserve a
typically indifferent feline distance from strangers.
References
- BBC News. Coronavirus: Tiger at Bronx Zoo tests positive for Covid-19.
2020, https://www.bbc.co.uk/news/world-us-canada-52177586
- Centers for disease control and prevention. Coronavirus Disease 2019
(COVID-19). 2020,
https://www.cdc.gov/coronavirus/2019-ncov/daily-life-coping/animals.html
- Shi J, Wen Z, Zhong G, et. al. Susceptibility of ferrets, cats, dogs,
and different domestic animals to SARS-coronavirus-2. 2020. doi:
https://doi.org/10.1101/2020.03.30.015347
- Schrödinger E. The present situation in quantum mechanics: a
translation of Schrodingers “cat paradox paper”. Proc. Am. Phil.
Soc., 124, 323-38.
- Mizumoto K, Kagaya K, Zarebski A, Chowell G. Estimating the
asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases
on board the Diamond Princess cruise ship, Yokohama, Japan, 2020.
2020, Euro Surveill. 25(10), 2-7. doi:
10.2807/1560-7917.ES.2020.25.10.2000180.
- Centers for disease control. Recommendation Regarding the Use of Cloth
Face Coverings, Especially in Areas of Significant Community-Based
Transmission. 2020,
https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/cloth-face-cover.html#studies
- Christakis NA, Abaluck J, Chevalier J, et al. The Case for Universal
Cloth Mask Adoption & Policies to Increase the Supply of Medical
Masks for Health Workers April 1 2020
https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3567438 [Epub
ahead of print]
- Bin-Reza F, Lopez Chavarrias V, Nicoll A, Chamberland ME. The use of
masks and respirators to prevent transmission of influenza: a
systematic review of the scientific evidence. 2012. Influenza Other
Respir Viruses. 6(4):257-67. doi: 10.1111/j.1750-2659.2011.00307.x.
Epub 2011 Dec 21.
- MacIntyre CR, Cauchemez S, Dwyer DE, et. al. Face mask use and control
of respiratory virus transmission in households. 2009. Emerg Infect
Dis. 15(2):233-41.
- Milton DK1, Fabian MP, Cowling BJ, Grantham ML,
McDevitt JJ. Influenza virus aerosols in human exhaled breath:
particle size, culturability, and effect of surgical masks. 2013 PLoS
Pathog. 9(3):e1003205. doi: 10.1371/journal.ppat.1003205.
- MacIntyre CR, Chughtai AA, Rahman B, Peng Y, Zhang Y, Seale H, Wang X,
Wang Q. The efficacy of medical masks and respirators against
respiratory infection in healthcare workers. 2017. Influenza Other
Respir Viruses. 11(6):511-517. doi: 10.1111/irv.12474.